Previous studies suggest physical activity improves cognition and lowers Alzheimer's disease (AD) risk. However, key AD pathogenic factors that are thought to be influenced by physical activity, particularly plasma amyloid-b (Ab) and Ab brain load, have yet to be thoroughly investigated. The objective of this study was to determine if plasma Ab and amyloid brain deposition are associated with physical activity levels, and whether these associations differed between carriers and non-carriers of the apolipoprotein E (APOE) e4 allele. Five-hundred and forty six cognitively intact participants (aged 60--95 years) from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (AIBL) were included in these analyses. Habitual physical activity levels were measured using the International Physical Activity Questionnaire (IPAQ). Serum insulin, glucose, cholesterol and plasma Ab levels were measured in fasting blood samples. A subgroup (n ¼ 116) underwent 11 C-Pittsburgh compound B (PiB) positron emission tomography (PET) scanning to quantify brain amyloid load. Higher levels of physical activity were associated with higher high density lipoprotein (HDL) (P ¼ 0.037), and lower insulin (Po0.001), triglycerides (P ¼ 0.019) and Ab 1À42/1À40 ratio (P ¼ 0.001). After stratification of the cohort based on APOE e4 allele carriage, it was evident that only non-carriers received the benefit of reduced plasma Ab from physical activity. Conversely, lower levels of PiB SUVR (standardised uptake value ratio) were observed in higher exercising APOE e4 carriers. Lower plasma Ab 1À42/1À40 and brain amyloid was observed in those reporting higher levels of physical activity, consistent with the hypothesis that physical activity may be involved in the modulation of pathogenic changes associated with AD.
INTRODUCTION
Dementia currently affects 35 million people worldwide, with the majority of those individuals having Alzheimer's disease (AD). 1 Currently, no cure is available; therefore, preventive strategies are essential to reduce disease incidence. Delaying AD onset and progression by 1 year has the potential to reduce worldwide incidence by 9 million cases. 2 In animal models and human cohorts, 3--7 the use of physical activity has been shown to enhance cognitive functioning and protect against dementia. Furthermore, positive associations have been observed between physical activity and an induction of brain-derived neurotrophic factor, cerebral blood flow, neurogenesis and synaptic plasticity; thus, indicating a possible protective role for physical activity against age-related cognitive decline and dementias, such as AD. 8--10 Another factor that may mediate the relationship between physical activity and brain health is the reduction of amyloid-b (Ab) levels in response to physical activity. In AD transgenic mice, physical activity has been shown to decrease brain amyloid load, as well as increasing levels of endopeptidase and neprilysin; enzymes that degrade Ab peptides. 11, 12 Moreover, a physical activity intervention study in humans showed a trend towards lower Ab 1À42 levels in individuals who undertook aerobic exercise, when compared with those carrying out a stretching regime. 13 It is likely that factors associated with cardiovascular disease (CVD) may have a role in the mechanism that links physical activity to Ab. Risk of CVD is lowered by physical activity through the modulation of selective biochemical changes, including alterations in high density lipoprotein (HDL), triglyceride and insulin levels. 14--16 It is believed that these biomarkers may have a role in the over production and/or decreased clearance of Ab, and thus provides insight into a potential mechanism for the association between physical activity and Ab. 17, 18 Furthermore carriers of the apolipoprotein E (APOE) e4 allele (a widely accepted genetic risk factor for sporadic AD) 19 have been shown to have both increased levels of CVD blood biomarkers and Ab, when compared with non-carriers of the e4 allele. 20--22 Through the use of brain imaging techniques such as magnetic resonance imaging and positron emission tomography (PET), emerging evidence suggests that physical activity is associated with brain structure. 23, 24 The radiotracer 11 C-Pittsburgh compound B (PiB) in PET scanning is now the gold standard in amyloid load quantification. 25 However, since PET scanning is not suitable for widespread screening of the population, other more accessible methods are needed. One approach has been to measure levels of blood-based biomarkers, including plasma Ab 1À42 . This is an attractive option, as it has the potential to be used as a screening tool in the wider community, but requires validation against PiB PET.
The current study was designed to examine the effect of physical activity on biomarkers associated with the development of AD in a large cohort of aged healthy men and women. More specifically, we aimed to investigate: (1) whether physical activity is associated with lower plasma Ab levels and brain amyloid load and (2) whether the presence of an apoE e4 allele results in a weaker association between physical activity and plasma Ab and brain amyloid.
MATERIALS AND METHODS
The study cohort consisted of 546 cognitively healthy males and females from an initial cohort of 1112 individuals participating in the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (AIBL) Study. 26 For inclusion, participants were required to demonstrate normal cognitive function (as determined by a panel of expert clinicians after 2 h of neuropsychological testing) and complete a physical activity questionnaire. Of the original 1112 individuals, 344 were not included due to diagnosis of mild cognitive impairment or AD. A further 217 were excluded due to noncompletion or inappropriate completion of the physical activity questionnaire and 5 did not have blood collected. This high number of incomplete or inappropriate completion of the questionnaire can be attributed to the strict inclusion rules applied to the questionnaire, thus increasing the validity of the data used. Subjects were given written instructions of the risks and benefits of their participation, and signed informed consent was obtained. Ethical approval was obtained from the participating Australian institutions' ethics committees: Austin Health, St Vincent's Health, Edith Cowan University and Hollywood Private Hospital.
Fasting blood measures
Blood samples were collected into serum pathology tubes and EDTA tubes containing Prostaglandin E1 (Sapphire Biosciences, Sydney, NSW, Australia, 33.3 ng ml
À1
) to prevent platelet activation, after a 10-h fast. Plasma was separated from whole blood contained in EDTA tubes by 15 min centrifugation at 200 g. The plasma was then stored at À80 1C in 250 and 500 ml aliquots, before being retrieved to undergo Ab 1À40 and Ab 1À42 quantification.
Plasma Ab was measured in two ways; using a commercial kit (INNO-BIA plasma Ab assay; Innogenetics, Inc., Gent, Belgium) and a double sandwich Enzyme-Linked Immuno-Sorbent Assay (Mehta ELISA). 27, 28 The INNO-BIA multiplex assays were run according to manufacturer instructions, and read on a Luminex xMAP reader system (Bio-Plex 200 System; Bio-Rad, Hercules, CA, USA). The Mehta ELISA utilises the monoclonal antibody 6E10 and two different biotinylated polyclonal antibodies for Ab 1À40 and Ab 1À42 measurement. The assay was carried out as previously described 28, 29 with measurements read at 450 nm (FluoroStar, BMG, Ortenberg, Germany). Results from each assay were used to calculate Ab 1À42/1À40 ratios. Lui et al. 30 have published data analysis on Ab measurements from the AIBL cohort in detail.
Fasting serum insulin (normal range o12 mU L 
Brain imaging
Data from PET imaging using PiB were collected from 116 cognitively healthy participants, as described previously. 22 Individuals were randomly selected from a pool of willing participants to undergo brain imaging. Briefly, PET images were acquired 40--70 min post PiB injection, from which a PET standardised uptake value is calculated. From this, a standardised uptake value ratio (SUVR) was calculated, using the cerebellar cortex as the reference region. 22 
Genotyping
Frozen whole blood samples containing EDTA/Prostaglandin E1 were thawed then centrifuged to separate leucocytes. DNA was isolated from the leucocytes, and PCR amplification and restrictions enzyme digestions took place to determine APOE genotype. 31 
Measurement of physical activity
Habitual physical activity levels were measured using the International Physical Activity Questionnaire (IPAQ). 32 The IPAQ is a subjective measure that asks participants to recall their physical activity from the previous 7 days. The questionnaire is separated into four sections; and consists of work activity, transportation activity, housework and leisure-time activity. Each question was allocated a metabolic equivalent score (MET), based on the intensity of the activity being undertaken. 32 The MET scores were then multiplied by the number of minutes per week spent participating in that activity to produce a 7-day activity score (METs min week
À1
). In an attempt to create a valid data set, we excluded incomplete questionnaires and questionnaires in which reported physical activity levels were two standard deviations above or below the mean. The IPAQ has been validated in various studies which have concluded that the questionnaire has acceptable properties for the measurement of physical activity. 32, 33 Statistical analyses All statistical analyses were conducted using statistical package for the social sciences (SPSS) version 17.0 (SPSS Inc., Chicago, IL, USA). The data collected from the IPAQ were not normally distributed, and therefore underwent a square root transformation. For all analyses, significance is indicated by Pp0.05. To determine the effect of physical activity (using the continuous physical activity variable) on PiB SUVR and blood biomarker levels, a Pearson's correlation was conducted, using gender, age and APOE e4 status as co-variates. We used a general linear model to determine the best predictors of the INNO-BIA Ab 1À42/1À40 ratio; and included the continuous physical activity variable, all CVD biomarkers, age, APOE e4 allele status, gender and body mass index as independent variables. Furthermore, a backward stepwise regression approach was used to obtain a model comprised only of variables significant at a 10% level. Participants were separated into tertiles dependent upon IPAQ physical activity levels. Individuals allocated to T1 reported the lowest activity (mean ¼ 1212 METs min week À1 ) and those allocated to T3 reported the highest activity (mean ¼ 7590 METs min week À1 ). The physical activity tertiles were recalculated for the PiB PET subgroup into equal tertiles (n ¼ 116) (T1 mean ¼ 1359.0, T2 mean ¼ 3444.9 METs min week À1 , T3 mean ¼ 7700.5 METs min week À1 ). Differences in the mean PiB SUVR and blood biomarkers across physical activity tertiles were analysed using a oneway analysis of variance, using Tukey's for post hoc analysis. Differences in biomarker levels were investigated further in an analysis of covariance that adopted a general linear model procedure, adjusting for gender, age and APOE e4 carrier status. Furthermore, the cohort was divided based upon APOE e4 allele carrier status.
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RESULTS

Descriptive statistics
The study participants had an average age of 69.6±6.8 years and 57% were females (Table 1) . APOE e4 carriers were evenly spread throughout the tertiles, as were levels of alcohol consumption and individuals who smoked tobacco products. When the cohort was stratified based on APOE e4 allele carriage (Supplementary Table 1 ), carriers of the allele were younger (68.6 ± 6.2) than noncarriers of the allele (70.0 ± 6.9). The PiB subset had similar demographic variables to the entire cohort, except that APOE e4 carriers were over-selected for, and represent 45% of the PiB subset (Supplementary Table 2) .
Pearson correlations Table 2 shows results of relationships between physical activity and several biomarkers. A significant correlation was observed between physical activity and the Ab 1À42/1À40 INNO-BIA ratio (R ¼ À0.14, P ¼ 0.001). Physical activity levels were also inversely correlated with serum insulin (R ¼ À0.17, Po0.001) and triglyceride levels (R ¼ À0.10, P ¼ 0.02), and positively correlated with HDL levels (R ¼ 0.09, P ¼ 0.04).
Analysis of variance and analysis of covariance Blood biomarkers. The results of the one-way analysis of variance and analysis of covariance for PiB SUVR and blood biomarkers over the tertiles are shown in Table 2 . Significant differences over the tertiles were observed for the INNO-BIA and Mehta ELISA Ab 1À42/1À40 ratio, insulin and HDL. Tukey's post hoc analysis showed that T3 had a significantly lower INNO-BIA Ab 1À42/1À40 ratio than T1 (P ¼ 0.008; T3 vs T1) (Figure 1 ). Furthermore, fasting levels of insulin were significantly lower in T3 when compared with T1 and T2 (Po0.001; T3 vs T1 and P ¼ 0.03; T3 vs T2). HDL was significantly higher in T2 and T3, when compared with T1 (P ¼ 0.01; T2 vs T1 and P ¼ 0.02; T3 vs T1). After stratification of the cohort based on APOE e4 allele status, one-way analysis of variance revealed that in non-APOE e4 carriers, T1 (P ¼ 0.004) and T2 (P ¼ 0.01) had a significantly higher INNO-BIA assay Ab 1À42/1À40 ratio when compared with T3 (see Figure 1 ) as well as after adjustment for age and gender (F ¼ 6.77, P ¼ 0.001), yet this was not seen within the e4 carrier group (P40.10).
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C-Pittsburgh Compound B Positron Emission Tomography. A positive trend was observed between neocortical PiB SUVR and levels of physical activity; however, this association did not reach statistical significance (F ¼ 2.06, P40.05). When the cohort was split into e4 carriers and non-carriers; a significant association between physical activity and PiB SUVR was observed in carriers of the APOE e4 allele (F ¼ 4.46, P ¼ 0.016), as well as after adjustment for age and gender (F ¼ 3.68, P ¼ 0.03). Post hoc analysis revealed that those in the lowest tertile had significantly higher levels of amyloid burden in the brain, compared with those in the highest tertile (P ¼ 0.03) (Figure 2 ). This association was not replicated in non-carriers of the APOE e4 allele (P40.05). Table 3a modelled physical activity, all CVD biomarkers, and various demographic variables as independent variable predictors of the INNO-BIA Ab 1À42/1À40 ratio (adjusted R-squared ¼ 0.048). In this analysis, the CVD blood biomarkers did not reach significance. A backward stepwise regression approach was used until all variables in the model were significant (adjusted R-squared ¼ 0.043). This model showed transformed physical activity variable, age and gender as the best predictors of the INNO-BIA Ab 1À42/1À40 ratio (Table 3b ).
General linear model
DISCUSSION
The purpose of the present study was to evaluate the effect of physical activity on AD-related biomarkers in 546 healthy older adults from the AIBL study cohort. The main findings from this study were (1) inverse associations between physical activity and insulin and triglycerides, while a positive correlation was observed between physical activity and HDL, (2) high physical activity was associated with lower plasma Ab 1À42/1À40 , (3) the association between physical activity and Ab 1À42/1À40 ratio was observed in non-e4 carriers, but not present in e4 carriers and (4) an association between higher physical activity levels and lower amyloid brain load as measured by PiB PET, in e4 carriers only.
An increase in CVD risk can increase an individual's chance of developing late-life AD and dementia. 18,34--40 For example, high levels of circulating cholesterol and triglycerides have been associated with an increased AD risk. 20, 41, 42 Furthermore, previous studies have reported that individuals with hyperinsulinaemia 
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have an increased risk of developing AD, with one study reporting AD risk was doubled in individuals with high insulin levels. 40 Consistent with previous findings, the current study shows higher physical activity to be correlated with higher HDL and lower serum triglycerides levels and insulin (Table 2) . 43, 44 These findings provide further insight into the association between physical activity and AD risk, through changes in CVD risk factors. Nevertheless, other factors, including dietary habits, are also important contributors in modulating CVD risk, but have not been examined in this study. The reduction in CVD risk received from higher physical activity levels in the present study was not reflected in total cholesterol and low density lipoprotein levels, both of which are associated with AD risk. 45 However, this unexpected finding may be explained by the high use of statins (25%) within the AIBL cohort.
In the present study, higher physical activity was associated with lower Ab 1À42/1À40 , thus indicating that the mechanism of Indicates correlation is significant at the 0.01 level. ANOVA, ANCOVA and partial correlation (Pearson correlations (using continuous physical activity variable) and ANCOVA (using physical activity tertiles) use age, gender and APOE e4 carriage status as covariates.) results of physical activity and mean biomarker levels. C-Pittsburgh compound B (PiB) standardised uptake value ratio (SUVR) measured in the International Physical Activity Questionnaire (IPAQ) tertiles for APOE e4 carriers (white-filled bars) and non-APOE e4 carriers (grey-filled bars). T1 ¼ 39, T2 ¼ 39, T3 ¼ 38. APOE, apolipoprotein E.
reduced AD risk through physical activity may involve direct action on the amyloid pathway (Table 2; Figure 1 ). While a significant association was noted, the R-squared values observed were low, and thus these results do not suggest a cause and effect relationship between physical activity and plasma Ab. Nevertheless, our study is the first to report an inverse correlation in humans between physical activity and plasma Ab 1À42/1À40 . To put our results into perspective, we must gain an understanding of the association between plasma Ab levels and AD risk. Cosentino et al. 46 reported an association between high plasma Ab 1À42 and increased cognitive decline, in a cohort of 880 dementia-free participants (average age 76.1). Conversely, Yaffe et al., 47 in a cohort of 997 healthy individuals with a mean age of 74.0, observed greater cognitive decline was associated with lower levels of Ab 1À42 . These findings are limited, as Yaffe et al. 47 used only changes on modified Mini Mental State Examination as a measure of cognitive decline; thus, it is likely that individuals who were not declining were also included in this group. The lack of a standardised measure of plasma Ab makes meaningful interpretation of data and previous literature difficult. This was evident in the current study as Ab 1À40 measured by the ELISA Mehta was slightly lower and Ab 1À42 slightly higher than that measured by the INNO-BIA assay. Nevertheless, we used both methods of measurement in the analysis with physical activity, as the Mehta ELISA has been correlated with clinical parameters in several prior studies, 27, 29 and, more recently, the INNO-BIA has become the plasma Ab test of choice, due to its higher sensitivity and greater levels of reproducibility between assays. 48 Based on our findings, we hypothesised that CVD biomarker levels were a factor in the association between physical activity and plasma Ab levels. To test this theory, we performed a general linear model to determine the value of CVD markers, along with physical activity and other demographic variables, as predictors of the INNO-BIA Ab 1À42/1À40 ratio level. We observed that of all the variables; physical activity, age and gender were the best predictors of INNO-BIA Ab 1À42/1À40 ratio levels, with little influence from CVD biomarkers levels. These results may indicate that in this data set physical activity independently influences both Ab levels and CVD factors.
An alternative explanation of our findings may be the influence of physical activity on circulating insulin levels and insulindegrading enzyme activity. Insulin-degrading enzyme has an important role in the degradation, and hence reduction, of circulating Ab. 36 In physically active individuals, a reduction of insulin, which consequently increases 'free' insulin-degrading enzyme, may facilitate the exercise-associated reduction in Ab. In addition to this, hyperinsulinaemia is more common in overweight subjects, and overweight and obesity are common among sedentary individuals and have been linked to an increase in Ab 1À42 . 49 It should be noted, however, that body mass index did not greatly differ across the tertiles, and further studies should include more accurate body fat measurements to evaluate this association.
To date, two prior studies have reported a relationship between physical activity and brain amyloid load, quantified by PiB PET imaging. 50, 51 Furthermore, one of these studies reported a moderating effect of the APOE e4 allele in the relationship between physical activity and amyloid deposition. 51 These results were replicated in the current study. In Figure 2 , neocortical PiB SUVR was similar between physically active (those in the highest tertile) APOE e4 carriers and non-carriers. However, those reporting the lowest levels of physical activity, and who were carriers of the APOE e4 allele had significantly higher levels of amyloid burden in the brain compared with non-e4 carriers reporting similar levels of physical activity. These results support those reported by Head et al., 51 who reported that sedentary APOE e4 allele carriers were at an increased risk of neocortical amyloid deposition.
Carriers of the APOE e4 allele typically have higher levels of brain amyloid and are at an increased risk for AD development. 19, 22 Previous studies have examined the influence of APOE e4 status on the relationship between physical activity and dementia risk, with inconclusive results. 52--54 When the current cohort was stratified on the basis of APOE e4 status, only the physically active non-e4 carriers had reduced plasma Ab 1À42/1À40 ratio. However, we find higher levels of physical activity were associated with lower brain amyloid load only in carriers of the APOE e4 allele. These apparently conflicting results may reflect different mechanisms at play for APOE e4 carriage and Ab in the brain vs the periphery. It is important to note that plasma Ab 1À42/1À40 ratio is lower than the rest of the cohort in physically active non-carriers of the APOE e4 allele (Figure 1 ). It could be argued that physical activity appears to be attenuating the high levels of brain amyloid associated with e4 carriers (Figure 2) , and that the apparent disconnect with plasma Ab levels may reflect poor clearance of Ab in the periphery in individuals with this e4 allele. Further research is essential to understand how physical activity impacts on Ab clearance from the brain in an APOE genotype-specific manner.
The findings from this study provide valuable information on the association between physical activity and AD risk. However, we acknowledge this study had limitations. The IPAQ may have been flawed due to over-reporting 55 or incomplete/inappropriate completion of questionnaires. 56 Our approach of limiting our data set only to those assumed to be correct reporters of physical activity may have affected our results; nevertheless, we are confident of the quality of the data presented, based on the consistent CVD biomarker level profiles demonstrated (for example, high physical activity and high HDL levels).
In conclusion, our findings indicate that a higher level of participation in physical activity may contribute to reducing levels of Ab 1À42/1À40 , and brain amyloid load, which is an indicator of AD pathogenesis. As this is a cross-sectional analysis, the causal direction of this association cannot be accurately predicted. Therefore, these findings need to be validated using longitudinal data from the AIBL study. The findings linking physical activity to a reduction in AD-associated biomarkers are significant to both the field of research and also to the general public. The establishment Physical activity and Ab plasma and brain levels BM Brown et al of clinical research exercise programs is important to gain further evidence to confirm physical activity contributes to healthy brain ageing. Furthermore, confirming the role of physical activity in the aetiology of AD, apart from its influence on vascular factors, is a key step in its adoption for prevention and further scientific focus as a key target in this devastating disease.
